CRL Charles River Laboratories International, Inc.
Healthcare$160.30+0.91%ClosedMarket Cap: $7.72B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$207.50
Target (Median)
$214.00
Target Range
$185.00 - $220.00
Upside from current price: 29.4%
Rating Distribution
2 Strong Buy10 Buy5 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Barclays | maintain | Overweight | Overweight |
| 2026-05-08 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-13 | JP Morgan | maintain | Neutral | Neutral |
| 2026-02-25 | UBS | maintain | Neutral | Neutral |
| 2026-02-20 | TD Cowen | maintain | Buy | Buy |
| 2026-02-20 | Mizuho | maintain | Neutral | Neutral |
| 2026-02-19 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-19 | Barclays | maintain | Overweight | Overweight |
| 2026-01-16 | Citigroup | maintain | Buy | Buy |
| 2026-01-13 | Evercore ISI Group | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Mon Dec 27 | $12.32 | $3.92B | 10 |
| Wed Dec 27 | $13.49 | $4.09B | 5 |
| Thu Dec 27 | $14.78 | $4.25B | 1 |
| Fri Dec 27 | $15.30 | $4.25B | 1 |